RNA N6-methyladenosine (m 6 A) modification induces catecholamine resistance and lipolysis inhibition in white adipose tissue (WAT), contributing to obesity pathogenesis; however, the responsible m 6 A readers remain elusive. Here, we identify YTHDF2 as a key m 6 A reader governing both β-adrenergic signaling and lipolytic machinery. YTHDF2 binds to m 6 A-marked mRNAs encoding β3-adrenergic receptor (Adrb3), adipose triacylglycerol lipase (Atgl), and comparative gene identification-58 (Cgi-58), promoting their degradation and thereby suppressing β-adrenergic signaling and lipolysis. Deletion of adipose Ythdf2 enhances lipolysis in vivo , in WAT explants ex vivo , and in cultured adipocytes. Conversely, YTHDF2 overexpression suppresses adipocyte lipolysis. High-fat diet feeding upregulates adipose YTHDF2 and increases its binding to Adrb3 , Atgl , and Cgi-58 mRNAs. Adipocyte-specific deletion of Ythdf2 protects against diet-induced obesity, insulin resistance, and liver steatosis. Moreover, deletion of adipose Mettl14 —but not Ythdf2 —disrupts brown adipose tissue development. These results unveil an adipose-intrinsic METTL3/METTL14/m 6 A/YTHDF2 pathway that drives catecholamine resistance and lipolysis suppression in obesity.